111

METACARE

No trades
See on Supercharts
Market capitalization
‪58.00 B‬KRW
−44KRW
‪−14.54 B‬KRW
‪55.75 B‬KRW
‪78.27 M‬
Beta (1Y)
0.35
Employees (FY)
22
Change (1Y)
−6 −21.43%
Revenue / Employee (1Y)
‪1.95 M‬KRW
Net income / Employee (1Y)
‪−507.59 K‬KRW

About METACARE


CEO
Beom-Yong Shin
Headquarters
Hwaseong-si
Founded
2009
ISIN
KR7118000009
FIGI
BBG000PCX4N5
METACARE Co., Ltd. engages in the manufacture, distribution, and sale of medical devices, and healthcare products. Its businesses include Medical, Wooridul Chair, and Bio divisions. The Medical division offers implants, medical equipment and instruments, traction therapy products, braces, and ultrasound equipment. The Wooridul Chair division provides chairs with chest support and spine structure. The Bio division deals with stem cell research activities such as recovery effects on spinal injury, chronic bone diseases, osteoporosis, degenerative arthritis, and disk disorder. The company was founded on December 1, 2009 and is headquartered in Hwaseong-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 118000 is 351 KRW — it hasn't changed in the past 24 hours. Watch METACARE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange METACARE stocks are traded under the ticker 118000.
118000 stock has risen by 2.92% compared to the previous week, the month change is a 1.44% rise, over the last year METACARE has showed a −14.18% decrease.
118000 reached its all-time high on Feb 20, 2012 with the price of 32,869 KRW, and its all-time low was 329 KRW and was reached on Oct 25, 2024. View more price dynamics on 118000 chart.
See other stocks reaching their highest and lowest prices.
118000 stock is 2.92% volatile and has beta coefficient of 0.35. Track METACARE stock price on the chart and check out the list of the most volatile stocks — is METACARE there?
Yes, you can track METACARE financials in yearly and quarterly reports right on TradingView.
118000 net income for the last quarter is ‪−1.72 B‬ KRW, while the quarter before that showed ‪13.61 B‬ KRW of net income which accounts for −112.64% change. Track more METACARE financial stats to get the full picture.
No, 118000 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 22.00 employees. See our rating of the largest employees — is METACARE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. METACARE EBITDA is ‪−4.17 B‬ KRW, and current EBITDA margin is −11.96%. See more stats in METACARE financial statements.
Like other stocks, 118000 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade METACARE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So METACARE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating METACARE stock shows the sell signal. See more of METACARE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.